These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7629817)

  • 1. Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance.
    Chiba P; Burghofer S; Richter E; Tell B; Moser A; Ecker G
    J Med Chem; 1995 Jul; 38(14):2789-93. PubMed ID: 7629817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on propafenone-type modulators of multidrug-resistance IV1): synthesis and pharmacological activity of 5-hydroxy and 5-benzyloxy derivatives.
    Chiba P; Tell B; Jäger W; Richter E; Hitzler M; Ecker G
    Arch Pharm (Weinheim); 1997 Nov; 330(11):343-7. PubMed ID: 9431026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.
    Ecker G; Chiba P; Hitzler M; Schmid D; Visser K; Cordes HP; Csöllei J; Seydel JK; Schaper KJ
    J Med Chem; 1996 Nov; 39(24):4767-74. PubMed ID: 8941391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological activity of the stereoisomers of GP-88, a propafenone-type modulator of multidrug resistance.
    Chiba P; Rebitzer S; Richter E; Hitzler M; Ecker G
    Bioorg Med Chem Lett; 1998 Apr; 8(7):829-32. PubMed ID: 9871549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined Hansch/Free-Wilson approach as predictive tool in QSAR studies on propafenone-type modulators of multidrug resistance.
    Tmej C; Chiba P; Huber M; Richter E; Hitzler M; Schaper KJ; Ecker G
    Arch Pharm (Weinheim); 1998; 331(7-8):233-40. PubMed ID: 9747179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of a nitrogen atom in modulators of multidrug resistance.
    Ecker G; Huber M; Schmid D; Chiba P
    Mol Pharmacol; 1999 Oct; 56(4):791-6. PubMed ID: 10496963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the chemosensitizing activity of modulators of multi-drug resistance via combined simultaneous analysis of sigmoidal dose-response curves.
    Ecker G; Chiba P; Schaper KJ
    J Pharm Pharmacol; 1997 Mar; 49(3):305-9. PubMed ID: 9231351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines.
    Hiessböck R; Wolf C; Richter E; Hitzler M; Chiba P; Kratzel M; Ecker G
    J Med Chem; 1999 Jun; 42(11):1921-6. PubMed ID: 10354400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
    Chiba P; Ecker G; Schmid D; Drach J; Tell B; Goldenberg S; Gekeler V
    Mol Pharmacol; 1996 Jun; 49(6):1122-30. PubMed ID: 8649352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of highly effective propafenone-type multidrug resistance modulators lacks effects on cardiac action potential and mechanical twitch parameters of rat papillary muscles.
    Schmid D; Staudacher DL; Loew HG; Spieckermann PG; Ecker GF; Kopp S; Chiba P
    J Pharmacol Exp Ther; 2003 Nov; 307(2):589-96. PubMed ID: 12966158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramolecular distribution of hydrophobicity influences pharmacological activity of propafenone-type MDR modulators.
    Pleban K; Hoffer C; Kopp S; Peer M; Chiba P; Ecker GF
    Arch Pharm (Weinheim); 2004 Jun; 337(6):328-34. PubMed ID: 15188222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCASE study of the multidrug resistance reversal activity of propafenone analogs.
    Klopman G; Zhu H; Ecker G; Chiba P
    J Comput Aided Mol Des; 2003; 17(5-6):291-7. PubMed ID: 14635722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements.
    Schmid D; Ecker G; Kopp S; Hitzler M; Chiba P
    Biochem Pharmacol; 1999 Nov; 58(9):1447-56. PubMed ID: 10513988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A.
    Corea G; Fattorusso E; Lanzotti V; Motti R; Simon PN; Dumontet C; Di Pietro A
    J Med Chem; 2004 Feb; 47(4):988-92. PubMed ID: 14761200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.
    Fleischer R; Wiese M
    J Med Chem; 2003 Nov; 46(23):4988-5004. PubMed ID: 14584949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators.
    Singh P; Paul K; Holzer W
    Bioorg Med Chem; 2006 Jul; 14(14):5061-71. PubMed ID: 16554161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
    Berger W; Hauptmann E; Elbling L; Vetterlein M; Kokoschka EM; Micksche M
    Int J Cancer; 1997 Mar; 71(1):108-15. PubMed ID: 9096673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.
    Chiba P; Holzer W; Landau M; Bechmann G; Lorenz K; Plagens B; Hitzler M; Richter E; Ecker G
    J Med Chem; 1998 Oct; 41(21):4001-11. PubMed ID: 9767638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.